FineHeart Announces Success of the First Stage of Its “First in Human” Clinical Study
Bordeaux, France, November 12, 2024 – FineHeart, a clinical-stage MedTech company developing
innovative medical devices for heart failure, has achieved a major milestone in its “First in Human” study,
clinically confirming the proof of concept for FlowMaker®.